Cisplatin prescribing information

Author: koqw

August undefined, 2024

WebCISplatin Injection Therapeutic Category: Oncology AP Rated Does Not Contain Natural Rubber Latex Bar Coded Preservative-free Safety Stickers and Related Instructions Enclosed With Each Carton Safety language printed on the top surface of every cap overseal is “CALL DR IF DOSE >100 MG/M 2 /CYCLE” WebCisplatin injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery and/or …

FDA approves sodium thiosulfate to reduce the risk of ototoxicity ...

WebAvelumab (BAVENCIO) maintenance is the only NCCN CATEGORY 1 and PREFERRED immunotherapy option for both cisplatin-eligible and -ineligible patients with locally advanced or metastatic UC that has not progressed on first-line platinum-containing chemotherapy. 1 Category 1=Based upon high-level evidence, there is uniform NCCN … WebCisplatin Injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, such as surgery … phobos clean 1.9.0

Gemzar Dosage Guide - Drugs.com

WebSep 1, 2024 · Refer to cisplatin prescribing information for additional information. Pediatric Use The safety and effectiveness of Pedmark have been established to reduce the risk of ototoxicity associated with … WebFULL PRESCRIBING INFORMATION WARNING: FATAL INFUSION-RELATED REACTIONS, SEVERE MUCOCUTANEOUS REACTIONS, HEPATITIS B VIRUS REACTIVATION and PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY Infusion-Related Reactions RITUXAN administration can result in serious, including fatal, infusion … WebCisplatin: 16729-288-11 1 mg/mL 50 mL Vial Product Image: Cisplatin: 16729-288-38 1 mg/mL 100 mL Vial Product Image: Cyanocobalamin Injection. Prescribing Information. ... Prescribing Information. Compare To NDC Number Strength Pack Size Details; Topotecan Injection: 16729-243-31 4 mg/4mL: Packs of 1 Vial Product Image: Z; phobos clean download

These highlights do not include all the information needed to use ...

WebHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTIONsafely and effectively. See full prescribing ... Gemcitabine Injection in combination with cisplatin is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or ... WebSee full prescribing information for complete boxed warning. Nephrotoxicity: cisplatin for injection can cause severe renal toxicity, including acute renal failure. Ensure adequate … phobos cleanedWebFeb 16, 2024 · Generic name: cisplatin [ sis-PLA-tin ] Brand names: Platinol, Platinol-AQ, Platinol (Restricted Access) Dosage forms: intravenous powder for injection (50 … phobos configs for 1.9.0

"Webcisplatin dosage adjustmen t, see manufacturer’s prescribing inform ation. In general, for severe (Grade 3 or 4) non-hematological toxicity, except alopecia and nausea/vomiting, … " - Cisplatin prescribing information

Cisplatin prescribing information

HIGHLIGHTS OF PRESCRIBING INFORMATION ... - Pfizer

WebApr 3, 2024 · On April 3, 2024, the Food and Drug Administration granted accelerated approval to enfortumab vedotin-ejfv (Padcev, Astellas Pharma) with pembrolizumab (Keytruda, Merck) for patients with locally... WebJun 23, 2024 · Print SmPC information 1. Name of the medicinal product 2. Qualitative and quantitative composition 3. Pharmaceutical form 4. Clinical particulars 5. Pharmacological properties 6. Pharmaceutical particulars 7. Marketing authorisation holder 8. Marketing authorisation number (s) 9. Date of first authorisation/renewal of the authorisation 10.

Did you know?

WebBefore sharing sensitive information, make sure you're on a federal government site. ... Efficacy for patients ineligible for cisplatin-containing chemotherapy was evaluated in Cohort 2 of EV-201 ... WebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Ovarian Cancer Gemcitabine in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. 1.2 Breast Cancer

WebFor dosage modifications for cisplatin, refer to the prescribing information for cisplatin. Table 1: Recommended Dosage Modifications for Adverse Reactions . Toxicity in Most Recent Treatment Cycle. PEMFEXY Dosage Modifications for Next Cycle Myelosuppressive toxicity [see Warnings and Precautions (5.1)] ANC less than 500/mm 3 and WebSCCHN: 75 mg/m2followed by cisplatin 100 mg/m2IV (day 1), followed by fluorouracil 1000 mg/m2per day as a 24-hr IV (days 1–4); for 3 cycles (2.5) For all patients: Premedicate with oral corticosteroids (2.6) Adjust dose as needed (2.7) DOSAGE FORMS AND STRENGTHS Injection: One-vial TAXOTERE: Single-dose vials 20 mg/mL and 80 mg/4 mL (3)

WebForHYCAMTIN for injection in combination with cisplatin, reduce the dose to 0.6 mg/m2/day(and further to 0.45 mg/m2 if necessary) for: febrile neutropenia (defined as neutrophil counts less than 1,000/mm3 with temperature of greater than or equal to 38.0 C (100.4 F) or administer G-CSF startingno sooner than 24 hours following the last dose WebHIGHLIGHTS OF PRESCRIBING INFORMATION • ... Docetaxel Injection in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). 2. DOSAGE AND ADMINISTRATION

WebThe recommended dosage of Gemcitabine Injection is 1250 mg/m 2 intravenously over 30 minutes on Days 1 and 8 of each 21-day cycle in combination with cisplatin 100 mg/m 2 …

WebJun 8, 2024 · FULL PRESCRIBING INFORMATION: CONTENTS* WARNING: NEPHROTOXICITY, PERIPHERAL NEUROPATHY, NAUSEA AND VOMITING and MYELOSUPPRESSION. 1 INDICATIONS AND … phobos client cleanWebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE CINVANTI, in combination with other antiemetic agents, is indicated in adults for the prevention of: • … phobos clean github phobos castle clashWebMar 8, 2024 · The recommended dosage of GEMZAR is 1250 mg/m 2 intravenously over 30 minutes on Days 1 and 8 of each 21-day cycle in combination with cisplatin 100 mg/m 2 administered intravenously on Day 1 after GEMZAR administration. Refer to cisplatin prescribing information for additional information. Dosage Modifications phobos captain 40kWebCARBOPLATIN (carboplatin) This product information is intended only for residents of the United States. for Consumers: CARBOPLATIN, Vial U.S. Patient information CARBOPLATIN Novaplus Vial, U.S. Patient Information for Healthcare professionals: CARBOPLATIN, Vial U.S. Physician Prescribing Information phobos childrenWebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Pemetrexed for Injection is indicated: In combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC). phobos cleanWebCISplatin for Injection, USP Therapeutic Category: Oncology IT’S BACK AS A STERILE POWDER 50 mg Sterile Powder Preservative Free Does Not Contain Natural Rubber Latex Bar Coded To order WGCC products, please contact your wholesaler or call Customer Service at 1-888-493-0861. Wholesaler Item Numbers SDS phobos character